MHH Researchers Put an End to Pathological Heart Growth
Innovative treatment approach for cardiac failure.
Heart conditions often have grave consequences. The dangerous process of pathological cardiac remodeling following a heart attack, e.g. is often irreversible. But scientists at MHH have been developing a new treatment option that may slow down or even reverse this process. Sponsored by the REBIRTH excellence cluster, said researchers have discovered a large amount of hitherto unknown ribonucleic acids (RNA) in the pathologically growing myocardial cells. Modulating the production of these RNAs could stop abnormal heart growth. Professor Dr. Dr. Thomas Thum, Head of the Institute of Molecular and Translational Therapeutic Strategies can tell us more.